会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Iontophoretic delivery device and method of making same
    • 离子电渗递送装置及其制造方法
    • US5543098A
    • 1996-08-06
    • US197665
    • 1994-02-17
    • Robert M. MyersFelix A. Landrau
    • Robert M. MyersFelix A. Landrau
    • A61N1/30C04B35/00
    • A61N1/30A61N1/0436A61N1/0448
    • An electrically powered transdermal iontophoretic delivery device (10, 20) and a method of making same is provided. The device utilizes electrode assemblies (8, 9) composed of a substantially homogenous blend of a polymeric matrix containing about 5 to 50 vol % of a conductive filler which forms a conductive network through the matrix, and up to about 50 vol % of the agent to be iontophoretically delivered through the skin. In the case of the donor electrode assembly, the agent is typically a drug and preferably a water soluble drug salt. In the case of the counter electrode assembly, the agent is typically an electrolyte salt. The homogenous blend eliminates the need for separate electrode and agent containing layers which require lamination.
    • 提供电动透皮离子电渗递送装置(10,20)及其制造方法。 该装置利用电极组件(8,9),该电极组件由包含约5至50体积%的导电填料的聚合物基质的基本上均匀的共混物组成,导电填料通过基体形成导电网络,并且至多约50vol%的试剂 通过皮肤离子电渗输送。 在供体电极组件的情况下,试剂通常是药物,优选水溶性药物盐。 在反电极组件的情况下,试剂通常是电解质盐。 均匀的共混物消除了对需要层压的单独的电极和含有层的层的需要。
    • 3. 发明授权
    • Iontophoretic delivery device and method of hydrating same
    • 静电输送装置及其液压方法
    • US5158537A
    • 1992-10-27
    • US605046
    • 1990-10-29
    • Ronald P. HaakJ. Richard GyoryFelix TheeuwesFelix A. LandrauNathan RothRobert M. Myers
    • Ronald P. HaakJ. Richard GyoryFelix TheeuwesFelix A. LandrauNathan RothRobert M. Myers
    • A61N1/30
    • A61N1/0436A61N1/0448A61N1/044
    • A dry-state iontophoretic drug delivery device (10, 70, 80) is provided. The device has drug and electrolyte reservoirs (15, 16) which are initially in a non-hydrated condition. A liquid-containing pouch (21, 22) is provided. In certain embodiments the liquid is contained in breakable capsules within the pouch. Water or other liquid can be released from the capsules in the pouch by squeezing or flexing the pouches (21, 22). Alternatively, the liquid can be released from the pouches (21, 22) using pouch piercing pins (36, 37). The liquid released from the pouches (21, 22) hydrates the drug and electrolyte reservoirs (15, 16) and activates the device. In another embodiment, the device (20, 20a) has liquid-containing gel layers (31, 32) which are initially separated from their respective electrode assemblies (8, 9). Liquid-wicking pathways (27, 28) are provided to carry the liquid from the gel layers (31, 32) to the drug and electrolyte layers (15, 16).
    • 提供了干态离子电渗药物输送装置(10,70,80)。 该装置具有最初处于非水合状态的药物和电解质储存器(15,16)。 提供含液囊(21,22)。 在某些实施方案中,液体包含在小袋内的可破坏胶囊中。 水或其它液体可以通过挤压或弯曲袋(21,22)从袋中的胶囊释放。 或者,可以使用袋刺穿销(36,37)从袋(21,22)中释放液体。 从袋(21,22)释放的液体使药物和电解质储存器(15,16)水合,并激活装置。 在另一个实施例中,装置(20,20a)具有最初与其各自的电极组件(8,9)分离的含液体凝胶层(31,32)。 提供液体芯吸路径(27,28)以将液体从凝胶层(31,32)运送到药物和电解质层(15,16)。
    • 5. 发明授权
    • Iontophoretic delivery device
    • 离子电渗输送装置
    • US5405317A
    • 1995-04-11
    • US938033
    • 1992-10-30
    • Robert M. MyersMark G. StahlFelix A. LandrauJ. Richard Gyory
    • Robert M. MyersMark G. StahlFelix A. LandrauJ. Richard Gyory
    • A61N1/30
    • A61N1/0436A61N1/0448
    • An electrically powered iontophoretic delivery device is provided. The device utilizes electrodes composed of a preferably hydrophobic polymeric matrix. The matrix contains about 10 to 50 vol % of a material capable of absorbing a liquid solvent, typically water, to provide a plurality of ion conducting pathways through the matrix. The matrix also contains about 5 to 40 vol % of a chemical species which is able to undergo either oxidation or reduction during operation of the device. Preferably, the solvent absorbing material is a hydrophilic polymer such as polyvinylpyrrolidone. For the anodic electrode, the chemical species should be able to undergo oxidation and is preferably either silver or zinc. For the cathodic electrode, the chemical species should be able to undergo reduction and is preferably silver chloride or a reducible metal.
    • PCT No.PCT / US91 / 03164 Sec。 371日期:1992年10月30日 102(e)日期1992年10月30日PCT 1991年5月7日PCT PCT。 第WO91 / 16946号公报 日期为1991年11月14日。提供电动离子电渗输送装置。 该装置使用由优选疏水性聚合物基质构成的电极。 该基质含有约10至50vol%的能够吸收液体溶剂(通常为水)的材料,以提供穿过基质的多个离子传导途径。 该基质还含有约5至40体积%的化学物质,其能够在装置的操作期间经历氧化或还原。 溶剂吸收材料优选为聚乙烯吡咯烷酮等亲水性聚合物。 对于阳极电极,化学物质应该能够经历氧化,并且优选是银或锌。 对于阴极电极,化学物质应该能够还原,并且优选为氯化银或可还原金属。
    • 6. 发明授权
    • Iontophoretic delivery device and method of hydrating same
    • 离子渗透输送装置及其水合方法
    • US5288289A
    • 1994-02-22
    • US881909
    • 1992-05-12
    • Ronald P. HaakJ. Richard GyoryFelix TheeuwesFelix A. LandrauNathan RothRobert M. Myers
    • Ronald P. HaakJ. Richard GyoryFelix TheeuwesFelix A. LandrauNathan RothRobert M. Myers
    • A61N1/30
    • A61N1/0436A61N1/0448A61N1/044
    • A dry-state iontophoretic drug delivery device (10, 70, 80) is provided. The device has drug and electrolyte reservoirs (15, 16) which are initially in a non-hydrated condition. A liquid-containing pouch (21, 22) is provided. In certain embodiments the liquid is contained in breakable capsules within the pouch. Water or other liquid can be released from the capsules in the pouch by squeezing or flexing the pouches (21,22). Alternatively, the liquid can be released from the pouches (21,22) using pouch piercing pins (36,37). The liquid released from the pouches (21,22) hydrates the drug and electrolyte reservoirs (15, 16) and activates the device. In another embodiment, the device (20, 20a) has liquid-containing gel layers (31,32) which are initially separated from their respective electrode assemblies (8, 9). Liquid-wicking pathways (27,28) are provided to carry the liquid from the gel layers (31,32) to the drug and electrolyte layers (15, 16).
    • 提供了干态离子电渗药物输送装置(10,70,80)。 该装置具有最初处于非水合状态的药物和电解质储存器(15,16)。 提供含液囊(21,22)。 在某些实施方案中,液体包含在小袋内的可破坏胶囊中。 水或其它液体可以通过挤压或弯曲袋(21,22)从袋中的胶囊释放。 或者,可以使用袋刺穿销(36,37)从袋(21,22)释放液体。 从袋(21,22)释放的液体使药物和电解质储存器(15,16)水合,并激活装置。 在另一个实施例中,装置(20,20a)具有最初与其各自的电极组件(8,9)分离的含液体凝胶层(31,32)。 提供液体芯吸路径(27,28)以将液体从凝胶层(31,32)运送到药物和电解质层(15,16)。
    • 7. 发明授权
    • Iontophoretic delivery device with single lamina electrode
    • 带单层电极的离子电渗输送装置
    • US5618265A
    • 1997-04-08
    • US592083
    • 1996-01-26
    • Robert M. MyersFelix A. Landrau
    • Robert M. MyersFelix A. Landrau
    • A61N1/30
    • A61N1/30A61N1/0436A61N1/0448
    • An electrically powered transdermal iontophoretic delivery device (10, 20) and a method of making same is provided. The device utilizes electrode assemblies (8, 9 ) composed of a substantially homogenous blend of a polymeric matrix containing about 5 to 50 vol % of a conductive filler which forms a conductive network through the matrix, and up to about 50 vol % of the agent to be iontophoretically delivered through the skin. In the case of the donor electrode assembly, the agent is typically a drug and preferably a water soluble drug salt. In the case of the counter electrode assembly, the agent is typically an electrolyte salt. The homogenous blend eliminates the need for separate electrode and agent containing layers which require lamination.
    • 提供电动透皮离子电渗递送装置(10,20)及其制造方法。 该装置利用电极组件(8,9),该电极组件由包含约5至50体积%的导电填料的聚合物基质的基本上均匀的共混物构成,该导电填料通过基质形成导电网络,并且至多约50体积% 通过皮肤离子电渗输送。 在供体电极组件的情况下,试剂通常是药物,优选水溶性药物盐。 在反电极组件的情况下,试剂通常是电解质盐。 均匀的共混物消除了对需要层压的单独的电极和含有层的层的需要。